Human CAMP/LL37/FALL39/Cathelicidin ELISA Kit (Colorimetric)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-27283
Key Product Details
Sample Type & Volume Required Per Well
Serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids (100 uL)
Sensitivity
0.062 ng/mL (example only; lot dependent)
Assay Range
0.156 - 10 ng/mL (example only; lot dependent)
Product Specifications
Assay Type
Sandwich ELISA
Kit Type
ELISA Kit (Colorimetric)
Reactivity
Human
Description
Assay Length: 4.5 hours
Precision
Intra-Assay Precision (Precision within an assay) %CV < 10 (example only; lot dependent)
Inter-Assay Precision (Precision between assays) %CV < 12 (example only; lot dependent)
Scientific Data Images for Human CAMP/LL37/FALL39/Cathelicidin ELISA Kit (Colorimetric)
ELISA: Human CAMP/LL37/FALL39/Cathelicidin ELISA Kit (Colorimetric) [NBP3-27283] -
ELISA: Human CAMP/LL37/FALL39/Cathelicidin ELISA Kit (Colorimetric) [NBP3-27283] - Standard Curve ReferenceKit Contents for Human CAMP/LL37/FALL39/Cathelicidin ELISA Kit (Colorimetric)
- Detection Reagent A
- Detection Reagent B
- Diluent Buffer
- Instruction manual
- Plate sealer for 96 wells
- Pre-coated 96T strip plate
- Standard
- Stop Solution
- TMB Substrate
- Wash Buffer (30 x concentrate)
Preparation and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: CAMP/LL37/FALL39
Long Name
Cathelicidin Antimicrobial Peptide
Alternate Names
CAMP, CAP18, CRAMP, FALL39
Gene Symbol
CAMP
Additional CAMP/LL37/FALL39 Products
Product Documents for Human CAMP/LL37/FALL39/Cathelicidin ELISA Kit (Colorimetric)
Product Specific Notices for Human CAMP/LL37/FALL39/Cathelicidin ELISA Kit (Colorimetric)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...